Background: Post-treatment alpha-fetoprotein (AFP) response has been reported to be
associated with prognosis of hepatocellular carcinoma (HCC) patients, but the results were …

AIM: To explore the prognostic value in the monitoring of treatment efficacy of serial α-
fetoprotein (AFP) in hepatocellular carcinoma (HCC) patients. METHODS: We searched …

COMMENTARY ON: Alphafetoprotein response after locoregional therapy for hepatocellular
carcinoma: oncologic marker of radiologic response, progression, and survival. Riaz A, Ryu …

AIM To investigate whether the change in pre-/post-operation serum alpha-fetoprotein (AFP)
levels is a predictive factor for hepatocellular carcinoma (HCC) outcomes. METHODS We …

Background Although many studies have confirmed the prognostic value of preoperative
alpha-fetoprotein (AFP) in patients with hepatocellular carcinoma (HCC), the association …

Purpose There are limitations in using radiologic evaluation to assess the treatment
outcome of patients with hepatocellular carcinoma (HCC). The use of serial α-fetoprotein …

BACKGROUND: Antiangiogenic therapy has become the most important treatment modality
for patients with advanced hepatocellular carcinoma (HCC). In this study, the authors …

Background. The role of serum α-fetoprotein (AFP) as a marker for treatment response in
patients with hepatocellular carcinoma (HCC) receiving systemic therapy is poorly defined …

Backgrounds: There are limitations in using only radiological criteria to evaluate treatment
outcomes in hepatocellular carcinoma (HCC). α‐fetoprotein (AFP) is regarded as an …

Background To investigate the prognostic values of the change of α-fetoprotein within 1
week after resection of hepatocellular carcinoma. Methods We retrospectively analyzed …